Alyeska Investment Group’s Larimar Therapeutics LRMR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.78M	Sell	617,211 -310,610	-33%	-$1.24M	0.01%	531
2025 Q4	$3.53M	Sell	927,821 -959,348	-51%	-$3.73M	0.01%	485
2025 Q3	$6.1M	Sell	1,887,169 -188,713	-9%	-$708K	0.02%	434
2025 Q2	$6M	Buy	2,075,882 +633,409	+44%	+$1.47M	0.02%	400
2025 Q1	$3.1M	Buy	1,442,473 +458,396	+47%	+$1.45M	0.01%	394
2024 Q4	$3.81M	Buy	984,077 +273,920	+39%	+$1.81M	0.01%	416
2024 Q3	$4.65M	Sell	710,157 -111,530	-14%	-$896K	0.02%	363
2024 Q2	$5.96M	Buy	821,687 +271,660	+49%	+$2.08M	0.03%	315
2024 Q1	$4.17M	Buy	+550,027	New	+$4.29M	0.03%	341
2022 Q4	–	Sell	-133,073	Closed	-$426K	–	469
2022 Q3	$426K	Buy	+133,073	New	+$333K	0.01%	363
2018 Q3	–	Sell	-20,833	Closed	-$2.56M	–	469
2018 Q2	$2.56M	Buy	+20,833	New	+$1.77M	0.02%	332
2016 Q3	–	Sell	-13,166	Closed	-$946K	–	502
2016 Q2	$946K	Buy	13,166 +267	+2%	+$21.1K	0.01%	388
2016 Q1	$1.03M	Sell	12,899 -1,277	-9%	-$101K	0.01%	354
2015 Q4	$1.07M	Buy	+14,176	New	+$2.28M	0.01%	338
2015 Q1	–	Sell	-10,285	Closed	-$3.81M	–	547
2014 Q4	$3.81M	Sell	10,285 -294	-3%	-$75.8K	0.06%	292
2014 Q3	$2.5M	Sell	10,579 -5,195	-33%	-$1.18M	0.05%	274
2014 Q2	$3.74M	Buy	+15,774	New	+$3.75M	0.08%	258